Last Updated on June 22, 2023

Anti-Obesity Drug Discovery and Development- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.00

SJR

 0.131

h-Index

 1

Rank

 23239

Important Details

Title Anti-Obesity Drug Discovery and Development
Type of Publication Book series
Discipline Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)
Impact Score 0.00
SCImago Journal Rank (SJR) 0.131
h-index 1
Overall Rank 23239
Publisher Name Bentham Science Publishers
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 22102698, 24679615
Coverage and History 2020-2021
Best Quartile Q4
Total Citations Received
(Last 3 Year)
0

About Anti-Obesity Drug Discovery and Development


Anti-Obesity Drug Discovery and Development is a book series published by Bentham Science Publishers. This book series covers the area[s] related to Drug Discovery, Pharmaceutical Science, Pharmacology (medical), etc. The coverage history of this book series is as follows: 2020-2021. The rank of this book series is 23239. This book series's impact score, h-index, and SJR are 0.00, 1, and 0.131, respectively. The ISSN of this book series is/are as follows: 22102698, 24679615.

The best quartile of Anti-Obesity Drug Discovery and Development is Q4. This book series has received a total of 0 citations during the last three years (Preceding 2022).


Anti-Obesity Drug Discovery and Development Impact Score 2022-2023


The latest impact score (IS) of the Anti-Obesity Drug Discovery and Development is 0.00. It is computed in the year 2023 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Graph


Check below the Impact Score trends of Anti-Obesity Drug Discovery and Development. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.00
2021 0.50

Anti-Obesity Drug Discovery and Development h-index


  Table Setting

The h-index of Anti-Obesity Drug Discovery and Development is 1. By definition of the h-index, this book series has at least 1 published articles with more than 1 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Anti-Obesity Drug Discovery and Development ISSN


The International Standard Serial Number (ISSN) of Anti-Obesity Drug Discovery and Development is/are as follows: 22102698, 24679615.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Anti-Obesity Drug Discovery and Development Ranking and SCImago Journal Rank (SJR)


The Anti-Obesity Drug Discovery and Development is ranked 23239 among 27955 Journals, Conferences, and Book Series. As per SJR, this book series is ranked 0.131.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Anti-Obesity Drug Discovery and Development Publisher


Table Setting

The publisher of Anti-Obesity Drug Discovery and Development is Bentham Science Publishers. The publishing house of this book series is located in the United Arab Emirates. Its coverage history is as follows: 2020-2021.


Call For Papers (CFPs)


Please check the official website of this book series to find out the complete details and Call For Papers (CFPs).


How to publish in Anti-Obesity Drug Discovery and Development


If your area of research or discipline is related to Drug Discovery, Pharmaceutical Science, Pharmacology (medical), etc., please check the book series's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Anti-Obesity Drug Discovery and Development?

The latest impact score of Anti-Obesity Drug Discovery and Development is 0.00. It is computed in the year 2023.


What is the h-index of Anti-Obesity Drug Discovery and Development?

The latest h-index of Anti-Obesity Drug Discovery and Development is 1. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Anti-Obesity Drug Discovery and Development?

The latest SCImago Journal Rank (SJR) of Anti-Obesity Drug Discovery and Development is 0.131. It is calculated in the year 2023.


What is the ranking of Anti-Obesity Drug Discovery and Development?

The latest ranking of Anti-Obesity Drug Discovery and Development is 23239. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Anti-Obesity Drug Discovery and Development?

Anti-Obesity Drug Discovery and Development is published by Bentham Science Publishers. The publication country of this book series is United Arab Emirates.


What is the abbreviation of Anti-Obesity Drug Discovery and Development?

This standard abbreviation of Anti-Obesity Drug Discovery and Development is .


Is "Anti-Obesity Drug Discovery and Development" a Journal, Conference or Book Series?

Anti-Obesity Drug Discovery and Development is a book series published by Bentham Science Publishers.


What is the scope of Anti-Obesity Drug Discovery and Development?

The scope of Anti-Obesity Drug Discovery and Development is as follows:

  • Drug Discovery
  • Pharmaceutical Science
  • Pharmacology (medical)

For detailed scope of Anti-Obesity Drug Discovery and Development, check the official website of this book series.


What is the ISSN of Anti-Obesity Drug Discovery and Development?

The International Standard Serial Number (ISSN) of Anti-Obesity Drug Discovery and Development is/are as follows: 22102698, 24679615.


What is the best quartile for Anti-Obesity Drug Discovery and Development?

The best quartile for Anti-Obesity Drug Discovery and Development is Q4.


What is the coverage history of Anti-Obesity Drug Discovery and Development?

The coverage history of Anti-Obesity Drug Discovery and Development is as follows 2020-2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
Journal of Competition Law and Economics Journal Oxford University Press 14815 29 0.72
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3221 84 3.68
International Journal of Mathematical Education in Science and Technology Journal Taylor and Francis Ltd. 10040 39 1.33
Mathematical Modelling and Analysis Journal Vilnius Gediminas Technical University 11315 27 1.75
Discourse Journal Routledge 6621 59 2.11
World Englishes Journal Wiley-Blackwell 4960 60 1.97
Journal, Indian Academy of Clinical Medicine Journal Indian Academy of Clinical Medicine 24608 16 0.06
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
Museum Management and Curatorship Journal Routledge 8168 37 2.65

Check complete list




Anti-Obesity Drug Discovery and Development Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.00
2021 0.50



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier | Netherlands

Advanced Drug Delivery Reviews
Elsevier | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Journal of Controlled Release
Elsevier | Netherlands

Bioengineering and Translational Medicine
John Wiley & Sons Inc. | United States

Apoptosis : an international journal on programmed cell death
Springer Netherlands | Netherlands

Journal of Nanobiotechnology
BioMed Central Ltd. | United Kingdom

Asian Journal of Pharmaceutical Sciences
Shenyang Pharmaceutical University | China

Journal of Pharmaceutical Analysis
Xi'an Jiaotong University | China

Bioconjugate Chemistry
American Chemical Society | United States

Phytomedicine
Urban und Fischer Verlag Jena | Germany

International Journal of Nanomedicine
Dove Medical Press Ltd. | New Zealand

Statistics in Biopharmaceutical Research
Taylor and Francis Ltd. | United Kingdom

Advanced Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

Expert Opinion on Drug Delivery
Taylor and Francis Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press | United Kingdom

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

See All